Next Article in Journal
Medicated Porridge (Karkkidaka Kanji) as a Healthy Seasonal Food—A Review
Previous Article in Journal
Muffin Enriched with Bioactive Compounds from Milk Thistle By-Product: Baking and Physico–Chemical Properties and Sensory Characteristics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Global Incidence of Attention Deficit/Hyperactivity Disorder among Children †

1
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
2
Department of Epidemiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
*
Author to whom correspondence should be addressed.
Presented at the 3rd International Electronic Conference on Brain Sciences (IECBS 2022), 1–15 October 2022; Available online: https://iecbs2022.sciforum.net/.
Biol. Life Sci. Forum 2022, 19(1), 6; https://doi.org/10.3390/IECBS2022-12942
Published: 30 September 2022
(This article belongs to the Proceedings of The 3rd International Electronic Conference on Brain Sciences)

Abstract

:
In this descriptive epidemiological study, age-specific rates for attention-deficit and hyperactivity disorder (ADHD) incidence among children (0–14 years) were presented (per 100,000). Joinpoint regression analysis was applied to calculate the average annual percent change (AAPC) with the corresponding 95% confidence interval (CI) to evaluate trends in 1990–2019. Global ADHD incidence was nearly threefold that of girls (307.9 and 114.4 per 100,000, respectively) in 2019. Trends for global ADHD incidence were significantly decreasing both in boys (AAPC = −0.4%, 95% CI = −0.4 to −0.3) and girls (AAPC = −0.4%, 95% CI = −0.5 to −0.3).

1. Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a chronic condition which involves a developmentally inadequate inattention level, hyperactivity, and/or impulsivity [1]. ADHD is among the most common childhood neurobehavioral disorders, persisting in a number of cases into adulthood [2,3,4]. A previous meta-regression analysis estimated that ADHD affects about 6% of children around the world, with a range from 1% to nearly 20% in school age children [2]. The significant differences in ADHD prevalence were described by geographic areas [2,5,6].
There have been only several studies reporting estimates of ADHD incidence trends, mostly indicating increasing incidence over the observed period [7,8]. However, some studies did not find an increase in ADHD incidence trends over the past years [5]. This study aimed to estimate the global incidence of attention-deficit and hyperactivity disorder among children in the last three decades.

2. Materials and Methods

2.1. Study Design

An observational descriptive epidemiological study was conducted to describe worldwide trends in the incidence of ADHD in the period 1990–2019.

2.2. Data Source

Data of ADHD incidence in children were obtained from the Global Burden of Disease Study 2019 [9]. In this study, age-specific rates of incidence for ADHD in children (0–14 years) were presented (per 100,000). Additionally, the socio-development level was quantified by the socio-demographic index (SDI), a composite measure comprised of income per capita, educational level for persons aged 15 years and older, and total fertility rate for women <25 years of age [9]. An SDI of 0 describes a theoretical minimum level of development as it pertains to health, while an SDI of 1 marks maximum level. Countries were divided into 5 SDI quintiles: low-, low–middle-, middle-, high–middle- and high-SDI countries.

2.3. Statistical Analysis

Joinpoint regression analysis was applied to determine the average annual percentage change (AAPC) with a 95% confidence interval (CI) to evaluate trends in 1990–2019 [10]. Additionally, disparities in trends of incidence by sex were assessed with a comparability test (specifically: test of parallelism) in order to determine if the two regression mean functions were parallel. A p value lower than 0.05 indicated statistical significance for all tests.

3. Results

Globally, there were 4,198,974 new ADHD cases in children (0–14 years) in 2019: it was diagnosed in 3,114,614 (74%) boys and 1,084,360 (26%) girls (Figure 1).
Global rate of ADHD incidence in boys was nearly threefold that in girls (307.9 per 100,000 and 114.4 per 100,000, respectively) in 2019 (Figure 2 and Figure 3). Globally, ADHD was a disorder that predominantly affected boys with a boy/girl sex ratio of approximately 3:1. Significantly decreasing trends for global ADHD incidence were observed both in boys (by −0.4% annually, 95% CI = −0.4 to −0.3) and girls (by −0.4% annually, 95% CI = −0.5 to −0.3) (Figure 2 and Figure 4). The trends of ADHD incidence in children in both sexes followed an oscillating nonlinear pattern, with a significant increase at the beginning of the observed period, and a continuously significant decrease in trends after 1995 in boys and after 1994 in girls. Based on the comparability test, global trends in incidence of ADHD in boys and girls were not parallel (final selected model rejected parallelism, p < 0.05).
In assessments of both sexes together, the highest ADHD incidence was observed in high-SDI countries (Figure 3). The incidence rates of ADHD in children across all SDI quintiles showed that boys experienced a higher disease burden compared with girls in 2019 (Figure 3). In boys, the highest incidence rate for ADHD in children was found in the high-SDI countries (521.28 per 100,000), followed by high–middle SDI countries (433.39 per 100,000), while the highest rates in girls were equally in high- and high–middle SDI countries (about 165.00 per 100,000).
Over the 1990–2019 period, a significant decrease in ADHD incidence rates in boys was noted in only one area—in middle-SDI countries (by −0.3% per year) (Figure 4). Contrary to that, the incidence rates of ADHD in boys significantly increased in high-SDI countries (by +0.2% per year), and low–middle- and low-SDI countries (equally by +0.1% per year). A significant increase in incidence of ADHD was registered in girls in high- and low–middle SDI countries (by +0.3% and +0.2% per year, respectively). In middle- and high–middle SDI countries a significant decrease was recorded (by −0.2% and −0.1% per year, respectively). Based on the comparability test, trends in incidence of ADHD by each SDI in boys and girls were not parallel (final selected model rejected parallelism, p < 0.05).

4. Discussion

The incidence of ADHD in children is still not well researched. Although not numerous, epidemiological studies on the ADHD incidence have shown increasing temporal trends of this disorder in some countries [3,8].
According to the available literature, until now there was no data on the global incidence of ADHD in children. Our study showed a decreasing trend in ADHD incidence among children in both sexes, with marked differences in trends by SDI. In contrast to the global trend, a pronounced increasing trend was observed in high SDI countries. The results of our study regarding the ADHD incidence among children are consistent with some previous research carried out in Spain [5], Slovenia [3], Canada [11], the USA [12], Germany [13].
The observed differences in ADHD incidence temporal trends in children could mainly be due to the implementation of new diagnostic criteria (ICD-10, etc.) and the use of different case definitions, overdiagnosis/underdiagnosis in different health care systems, geographical and demographic factors, different observation periods, and differences in study methodology.
In conclusion, ADHD remains one of the most common neurodevelopmental disorders in children, although a decreasing global trend in incidence was observed. To explain the reasons for variations in ADHD incidence in children across the world, future analytical longitudinal studies are needed.

Author Contributions

Conceptualization, I.I. and M.I.; methodology, I.I. and M.I.; software, I.I. and M.I.; validation, I.I. and M.I.; formal analysis, I.I. and M.I.; investigation, I.I. and M.I.; resources, I.I. and M.I.; data curation, I.I. and M.I.; writing—original draft preparation, I.I.; writing—review and editing, I.I. and M.I.; visualization, I.I. and M.I.; supervision, M.I.; project administration, M.I.; funding acquisition, M.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Faculty of Medical Sciences, University of Kragujevac (Ref. No.: 01-14321, 13 November 2017), entitled “Epidemiology of the most common health disorders”.

Informed Consent Statement

Not applicable. No patient approvals were sought nor required for this study. Namely, as our model-based analysis used aggregated data, patients were not involved in the research.

Data Availability Statement

Data is contained within the article.

Acknowledgments

This study is conducted as the part of project No. 175042 supported by Ministry of Education, Science and Technological development, Republic of Serbia, 2011–2022.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. American Psychiatric Association. Attention-deficit/hyperactivity disorder. In Diagnostic and Statistical Manual of Mental Disorders DSM-5, 5th ed.; American Psychiatric Association: Arlington, TX, USA, 2013. [Google Scholar]
  2. Polanczyk, G.; de Lima, M.S.; Horta, B.L.; Biederman, J.; Rohde, L.A. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164, 942–948. [Google Scholar] [CrossRef] [PubMed]
  3. Štuhec, M.; Švab, V.; Locatelli, I. Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: A database study from a national perspective. Croat. Med. J. 2015, 56, 159–165. [Google Scholar] [CrossRef] [PubMed]
  4. Harpin, V.A. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch. Dis. Child 2005, 90, i2–i7. [Google Scholar] [CrossRef] [PubMed]
  5. Pérez-Crespo, L.; Canals-Sans, J.; Suades-González, E.; Guxens, M. Temporal trends and geographical variability of the prevalence and incidence of attention deficit/hyperactivity disorder diagnoses among children in Catalonia, Spain. Sci. Rep. 2020, 10, 6397. [Google Scholar] [CrossRef] [PubMed]
  6. Albatti, T.H.; Alhedyan, Z.; Alnaeim, N.; Almuhareb, A.; Alabdulkarim, J.; Albadia, R.; Alshahrani, K. Prevalence of attention deficit hyperactivity disorder among primary school-children in Riyadh, Saudi Arabia; 2015–2016. Int. J. Pediatr. Adolesc. Med. 2017, 4, 91–94. [Google Scholar] [CrossRef] [PubMed]
  7. Hire, A.J.; Ashcrof, D.M.; Springate, D.A.; Steinke, D.T. ADHD in the United Kingdom: Regional and Socioeconomic Variations in Incidence Rates Amongst Children and Adolescents (2004–2013). J. Atten. Disord. 2018, 22, 134–142. [Google Scholar] [CrossRef] [PubMed]
  8. Madsen, K.B.; Ersbøll, A.K.; Olsen, J.; Parner, E.; Obel, C. Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: A Danish cohort study. Int. J. Heal. Geogr. 2015, 14, 24. [Google Scholar] [CrossRef] [PubMed]
  9. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results; Institute for Health Metrics and Evaluation (IHME): Seattle, WA, USA, 2020; Available online: http://ghdx.healthdata.org/gbd-results-tool (accessed on 29 August 2022).
  10. Kim, H.J.; Fay, M.P.; Feuer, E.J.; Midthune, D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000, 19, 335–351. [Google Scholar] [CrossRef]
  11. Vasiliadis, H.M.; Diallo, F.B.; Rochette, L.; Smith, M.; Langille, D.; Lin, E.; Kisely, S.; Fombonne, E.; Thompson, A.H.; Renaud, J.; et al. Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study. Can. J. Psychiatry 2017, 62, 818–826. [Google Scholar] [CrossRef]
  12. Chung, W.; Jiang, S.F.; Paksarian, D.; Nikolaidis, A.; Castellanos, F.X.; Merikangas, K.R.; Milham, M.P. Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups. JAMA Netw. Open 2019, 2, e1914344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Lindemann, C.; Langner, I.; Kraut, A.A.; Banaschewski, T.; Schad-Hansjosten, T.; Petermann, U.; Petermann, F.; Schreyer-Mehlhop, I.; Garbe, E.; Mikolajczyk, R.T. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J. Child Adolesc. Psychopharmacol. 2012, 22, 307–314. [Google Scholar] [CrossRef]
Figure 1. Number of new cases of attention-deficit and hyperactivity disorder in the world, by sex, 1990–2019.
Figure 1. Number of new cases of attention-deficit and hyperactivity disorder in the world, by sex, 1990–2019.
Blsf 19 00006 g001
Figure 2. Trends in global incidence of attention deficit/hyperactivity disorder in children (0–14 years), 1990–2019; a Joinpoint regression analysis: Males: 4 Joinpoints versus Females: 5 Joinpoints.
Figure 2. Trends in global incidence of attention deficit/hyperactivity disorder in children (0–14 years), 1990–2019; a Joinpoint regression analysis: Males: 4 Joinpoints versus Females: 5 Joinpoints.
Blsf 19 00006 g002
Figure 3. Incidence of attention deficit/hyperactivity disorder in children (global and by Socio-demographic index—SDI), by sex, 2019.
Figure 3. Incidence of attention deficit/hyperactivity disorder in children (global and by Socio-demographic index—SDI), by sex, 2019.
Blsf 19 00006 g003
Figure 4. Trends in incidence of attention deficit/hyperactivity disorder in children (global and by Socio-demographic index—SDI), by sex, 1990–2019; a Joinpoint regression analysis. * statistically significant, p < 0.05.
Figure 4. Trends in incidence of attention deficit/hyperactivity disorder in children (global and by Socio-demographic index—SDI), by sex, 1990–2019; a Joinpoint regression analysis. * statistically significant, p < 0.05.
Blsf 19 00006 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ilic, I.; Ilic, M. Global Incidence of Attention Deficit/Hyperactivity Disorder among Children. Biol. Life Sci. Forum 2022, 19, 6. https://doi.org/10.3390/IECBS2022-12942

AMA Style

Ilic I, Ilic M. Global Incidence of Attention Deficit/Hyperactivity Disorder among Children. Biology and Life Sciences Forum. 2022; 19(1):6. https://doi.org/10.3390/IECBS2022-12942

Chicago/Turabian Style

Ilic, Irena, and Milena Ilic. 2022. "Global Incidence of Attention Deficit/Hyperactivity Disorder among Children" Biology and Life Sciences Forum 19, no. 1: 6. https://doi.org/10.3390/IECBS2022-12942

Article Metrics

Back to TopTop